Approval · Notice of Compliance 11226 · 2010
EVICEL: Notice of Compliance 11226
Issued April 8, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 11226
- Date
- April 8, 2010
- Company
- Omrix Biopharmaceuticals LtdNess Ziona, --, Israel
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change to manufacturing process and name
- Therapeutic class
- Hemostatic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| EVICEL | 02348497 | Cancelled Post Market |
Medicinal ingredients
- FIBRINOGEN (HUMAN) 90 MG per ML
- THROMBIN (HUMAN) 1,200 UNIT per ML